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doi:10.1016/j.ejvs.2009.10.008Abstract Background: To evaluate the therapeutic value of endovascular techniques for the
treatment of profunda femoris artery obstructive disease (PFAOD) in critical limb ischaemia
(CLI) patients, with technically demanding open profunda repair.
Design: Retrospective study of prospectively collected data of 15 consecutive CLI patients with
technically demanding surgical treatment of PFAOD, that were treated by endovascular means
in two European Centers of Vascular Surgery.
Materials: All patients had critical limb ischaemia with a history of at least two previous
vascular reconstructions in the ipsilateral groin and severe co-morbid conditions. All patients
had good common femoral artery flow, long occlusion of the superficial femoral and popliteal
arteries and impairment of crural arteries.
Methods: Twelve patients underwent balloon angioplasty alone and, in the other three cases,
an additional stent placement was necessary, due to flow-limiting dissection. The follow-up
(mean 29.2 10 months) included a surveillance protocol with the best medical treatment
and duplex scanning at 1, 3, 6, 12 months and yearly thereafter.
Results: The endovascular approach was technically successful in all cases and the procedure-
related morbidity and mortality rates were 0% for the entire follow-up period. The 3-year
primary and secondary patency rates of the treated segment were 80% and 86.7%, respec-
tively. The limb salvage rate was 93.3%.10963243.
s A. Pitoulias contributed equally.
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
PTA of Profunda Femoris Artery 309Conclusions: The outcome of our series underscores the therapeutic value of balloon
angioplasty in cases of severe PFAOD, as bailout treatment in critical limb ischaemia patients
with technically demanding open profunda repair. This procedure can be repeated easily if
significant restenosis occurs and provides a useful tool in selected cases.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Critical limb ischaemia (CLI) represents the final stage of
advanced peripheral arterial occlusive disease. Profunda
femoris artery (PFA) is the main vessel providing arterial
blood supply to thigh muscles. In CLI patients with severely
diseased or occluded superficial femoral artery, the PFA
represents the main collateral pathway to maintain distal
extremity arterial flow. In these patients, the progression
of atherosclerosis in profunda femoris artery obstructive
disease (PFAOD) increases significantly the occurrence of
rest pain and the risk of limb loss. Over time, in selected
cases of severe PFAOD with long occlusion of the superficial
femoral and popliteal arteries, the revascularisation of PFA
by surgical techniques has been shown to have good
results.1e3 However, patients suffering from CLI usually
have severe co-morbidities and history of multiple vascular
reconstuctions.3 Scars in the groin, compromised lymph
drainage or the presence of synthetic material from
previous operations make the surgical exposure and
reconstruction of PFA technically demanding and increase
the possibility of wound and graft infections.
In this cohort of high peri-proceduralrisk CLI patients,
the percutaneous transluminal angioplasty (PTA) through
the contralateral femoral artery and crossover manoeuvre
might offer a reliable option for sufficient revascularisation
of PFA and consecutive limb salvage. The present study
reports on the mid-term outcome of a series of 15 CLI
patients with technically demanding open repair of PFA,
who were treated by endovascular means. Moreover, the
current article attempts to discuss the indications and gives
recommendations for the endovascular treatment of CLI
patients with severe PFAOD.Materials and Methods
Between September 2005 and March 2008, 15 consecutive
patients with technically demanding ’open’ PFAOD repair
underwent PTA alone or stent-supported angioplasty of the
PFA in our institutions in Mu¨nster (nZ 12) and Cologne
(nZ 3), Germany. The treatment protocol was approved by
the Ethical Committees and the series consisted of 10 men
and five women (mean age 75.6 12 years, range 68e96
years). Table 1 shows the demographics and clinical
condition data of our series. All patients had serious
cardiovascular co-morbidities (such as chronic obstructive
pulmonary disease, previous myocardial infarction or
coronary revascularisation in the last 3 months, congestive
heart failure, American Society of Anaesthesiology score
3). All patients had at least two previous vascular recon-
structions in the ipsilateral groin making an open repair
technically demanding. Table 2 shows all previous vascularprocedures of our patients. Three of these patients had
already undergone an amputation (two patients above the
knee and one patient below the knee) and developed
stump-threatening ischaemia. The remaining 12 patients
experienced nocturnal pain and six of them showed foot or
digital ischaemic ulceration. In all cases, the angiography
showed occlusion of the superficial femoris artery (SFA) or
of a previous femoropopliteal bypass. In addition, the 12
(non-amputated) patients had angiographic evidence of
concomitant occlusion of the ipsilateral popliteal artery
with one (nZ 5), two (nZ 4) or all three (nZ 3) crural
arteries patent. The median pain-free walking distance of
these patients on a standardised treadmill test (at 3.2 Km/h
and 0 angle with the flat ground) was as low as 20 m.
In addition, six of these patients had morbid obesity with
median body mass index of 32.8 (range 28e41.2). The
profunda popliteal collateral index (PPCIZ AKSP e BKSP/
AKSP, where AKSP is the above-knee segmental pressure
and BKSP is the below-knee segmental pressure) was also
recorded.4 The median PPCI in 12 patients was 0.3.
All patients were treated by a vascular surgeon in an
operation theatre equipped with an angio-suite. Using local
anaesthesia with infiltration by 10 ml of 1% xylocaine, the
contralateral common femoral artery was punctured and
a 5F sheath was introduced in the contralateral external
iliac artery. A pigtail angiographic catheter was advanced in
the renal aortic segment and an aortoiliac and peripheral
arteries angiogram was performed. Following a crossover
manoeuvre with the pigtail catheter and a hydrophilic
0.035-inch guide wire (Radifocus, Terumo Europe, Leuven,
Belgium), the 5F sheath was changed with a long (45 cm)
flexible 6F sheath (Destination, Terumo Europe, Leuven,
Belgium). A femoral angiogram was performed. Ostial
stenosis and stenosis or occlusion of the PFA segment until
the first perforator artery was considered as the proximal
lesion. Stenosis or occlusion of the PFA localised between
the first and second perforator arteries was considered as
the middle segment lesion. Using road mapping, the PFA
was recanalised by a soft 0.018-inch guide wire (V-18,
Boston Scientific, Watertown, MA, USA) and a balloon
catheter. Seven patients underwent PTA of the proximal
segment of PFA, including four ostial stenoses (Fig. 1) and
eight patients of the middle segment. The balloon
catheters used were 3e6 mm in diameter and 40e150 mm
in length (in six cases we used the Sailor e Invatec,
Roncadelle, Italy; in three cases, the Admiral e Invatec,
Roncadelle, Italy; in one case, the Submarine plus e Inva-
tec, Roncadelle, Italy; in one case, the Pacific xtreme e
Invatec, Roncadelle, Italy and in one case the Fox Plus e
Abbot Vascular, Redwood City, CA, USA). Angioplasty was
performed in all cases by balloon inflation at 8 atm for
2 min (Fig. 1). In three cases, the balloon PTA resulted in
flow-limiting dissection of the treated segment and
Table 2 History of previous vascular procedures requiring surgi
Patient
No
Aortobifemoral
Y-prothesis
Femoro-distal
bypass
Cross
bypa
1 O O
2 O O
3 O
4 O
5a O O
6 O
7 O O
8 O O
9a O
10 O O
11 O
12 O O
13 O O
14 O O
15 O
a Patients No 5 and 9 had a history of 2 previous PTAs.
Table 1 Demograhics and clinical characteristics of 15
critical limb ischaemia (CLI) patients, who underwent
endovascular treatment of the profunda femoris artery.
Male/female 10/5
Age (mean sd) 75.6 12
Rutherford CLI
classification
category 4 6e40%
category 5 6e40%
category 6 3e20%
Hypertension 12e80%
Diabetes 7e46.7%
Hyperlipidemia 8e53.3%
Smoking 8e53.3%
Coronary disease 11e73.3%
Chronic obstructive
pulmonary disease
6e40%
Congestive heart failure 3e20%
ASA III/IV 12e80%
Previous vascular
operationsa
15e100%
Median Body Mass Index 32.8
Median profunda popliteal
collateral indexb
0.3
pre-PTA post-PTA
(1st month)
p
Median ipsilateral
ankleebrachial indexb
0.3 0.6 0.005
Median pain-free walking
distanceb
20 125 0.005
a All patients had at least 2 previous revascularization
procedures in the ipsilateral groin and 3 of them had addition-
ally an amputation with stump-threatening ischaemia.
b In twelve patients (excluding the patients with previous
amputation). Walking distance was measured on a standardised
treadmill test at 3.2 km/h and 0

angle with the flat ground.
310 K.P. Donas et al.a nitinol stent was placed (Life Stent NT35, 6 80 mm e
Edwards Lifesciences, Irvine, CA, USA; Xpert 4 40 mm e
Abbot Vascular, Redwood City, CA, USA; and Smart
6 60 mm e Cordis Endovascular Systems, Miami Lakes, FL,
USA). Finally, a control angiogram was performed to ensure
the successful revascularisation of the PFA and peripheral
arteries, and a percutaneous closure system (AngioSeal, St.
Jude Medical, St. Louis, MO, USA) was used in all cases.
In addition, in the six patients with foot or digital ulcera-
tion, we performed surgical debridement, and this was
followed by conventional (with non-specific agents) wound
care until the complete healing of the ulcers.
All patients were set in a clinical surveillance pro-
gramme with lifestyle and atherosclerotic risk factors
modifications, as well as in a follow-up programme, which
included clinical examination with ankleebrachial index
(ABI) and duplex ultrasound before patients’ discharge as
well as in 1, 3, 6, 12 months’ interval and yearly thereafter.
Medication treatment postoperatively included aggressive
lipid control and diabetes mellitus management as well as
double anti-platelet agents (acetylsalicylic acid 100 mg and
clopidogrel 75 mg daily) for 2 months post-interventionally,
and lifelong acetylsalicylic acid alone.
Statistical analysis of the prospectively collected data
was performed with the SPSS 13.0 software (SPSS Inc,
Chicago, IL, USA). The persistence of profunda femoris
patency and limb salvage during the follow-up period were
evaluated by Kaplane-Meier life-table analysis. The pre-
and post-procedural pain-free walking distance and ABI
were compared by non-parametrical Wilcoxon test as
appropriate. Statistical significance was determined at
p< 0.05.
Results
The recanalisation and angioplasty of PFA was technically
successful in all cases and the procedure-related morbiditycal exposure or puncturing in the ipsilateral groin.
-over
ss
Iliofemoral remote
endarterectomy &
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Figure 1 Intra-operative angiogram of profunda femoris PTA in a critical limb ischaemia patient with occluded the superficial
femoral artery and failed femoral-popliteal bypass graft. (A) Double, (ostial and filiform) stenosis of proximal profunda femoris
artery. (B) Successful recanalisation and balloon angioplasty of the lesions with 5 mm balloon angioplasty. (C) Result of PTA.
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In one patient, despite the primary successful stent-sup-
ported angioplasty of the PFA, a progressive below-the-
knee stump-threatening ischaemia occurred with consecu-
tive proximal re-amputation above the knee. All other
stump and foot or digital ulcers were healed within the first
month of follow-up and the patients were relieved from
their nocturnal pain. At the first month’s follow-up, the
median ABI increased from 0.3 to 0.6 (pZ 0.005) and
a sustained improvement was recorded at 18 and 36 months
with a median ABI of 0.7 (pZ 0.005) and 0.66 (pZ 0.005),
respectively. The standardised treadmill test showed
improvement of the median pain-free walking distance
within the first month from 20 m to 125 m (pZ 0.005), and
within 18 months up to 185 m (pZ 0.005).
During the follow-up, one patient presented with acute
onset of rest pain at 14 months after the primary inter-
vention (stenting of a proximal PFA lesion). The urgent
angiogram showed stent kinking and occlusion, and
a secondary intervention by balloon angioplasty was
necessary to maintain the patency of PFA. Finally, in twoFigure 2 Cumulative primary, secondary patency and limb salva
profunda femoris artery PTA.patients, one with proximal and one with middle segment
of the PFA balloon angioplasties, a restenosis (50%) was
diagnosed by duplex sonography at 12 and 24 months of
follow-up, respectively. The patients had no clinical
consequences and were treated conservatively. The post-
interventional course of the patients was uneventful,
without recurrence of digital ulceration and the current
pain-free walking distance is 80 m (from 20 m preopera-
tively) for both patients.
The median length of follow-up was 24 months (range
12e43, mean stdvZ 29.2 10). The 3-year cumulative
primary and secondary patency rates were 80% and 86.7%,
respectively, and the limb salvage rate was 93.3% (Fig. 2).Discussion
Progression of atherosclerosis in PFA is usually restricted
to the proximal or middle part of the artery, sparing
the distal profunda, which can continue serving the
collateral function. In selected cases of CLI patients, thege in 15 patients with critical limb ischaemia who underwent
Table 3 Anatomic characteristics of PFA lesions and
impairement of crural vessels.
Patient
No
Proximal PFA
stenosis (nZ 7)
Middle PFA
stenosis (nZ 8)
Patent crural
vessels
(medianZ 1.8)
1 O 1
2b O 3
3 O 2
4 O 3
5a O 0
6 O 1
7a O 0
8 O 2
9 O 1
10b O 1
11 O 2
12b O 2
13 O 3
14a O 0
15 O 1
a Patients No 5, 7 and 14 had a history of a previous major
amputation (2 of them above and 1 below the knee).
b Patients No 2, 10 and 12 underwent stent-supported PTA.
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excellent long-term patency rates.5e7 In rare cases of CLI
patients with a history of multiple vascular reconstructions
in the ipsilateral groin, the surgical exposure of PFA might
be technically demanding and endovascular techniques
could offer a better therapeutic approach, especially in
high-risk patients. However, there is insufficient evidence
for the role of endovascular techniques in patients suffering
from PFAOD. The literature provides scant and controver-
sial information about the PFA-balloon PTA and stenting.
Several previous reports showed that PTA of PFA was safe
and effective in limb-threatening ischaemia. 8e12 On the
contrary, Dick et al. reported that PTA of PFA in CLI
patients does not yield a sustained haemodynamic or
clinical benefit.13 The results of our series are in context
with the majority of published experience and underscore
that PTA of PFA is a safe and effective treatment for limb
salvage in carefully selected patients. One possible
explanation for this controversy may be the selection of
patients and the presence of co-existing disease in the
common femoral artery or crural vessels that are related
with compromised PTA inflow and outflow.
In our study all patients had good common femoral
inflow from previous open or endovascular iliac and
common femoral reconstructions. In addition, we recorded
the PPCI as a useful test to select which patients could
benefit from revascularisation of PFA. The median PPCI was
0.3 and this was a good predictor for the adequacy of
collateral pathways from the PFA to the crural arteries.
However, for a satisfactory outcome, it is obvious that the
distal runoff plays an important role. Diehm et al. pub-
lished a series from 21 endovascular revascularisations of
PFA and concluded that isolated PFA revascularisation was
insufficient to support wound healing, but it might be
a treatment option in CLI patients with rest pain.14 This isin contrast with our results that showed post-interventional
healing of all but one ischaemic ulceration. A possible
explanation of this may be the quality of distal runoff. The
median number of patent crural arteries in our series was
1.8 (Table 3). In our experience, the only angiographic
prerequisites for PTA’s technical success are the presence
of a PFA´s ostium stump for proper recognition of the
recanalisation plan and the patency of the post-stenotic
PFA’s segment, which could provide the blood supply to
infragenicular collaterals. In addition, good inflow from the
common femoral artery and adequate crural outflow are
essential to achieve good long-term results. At present, no
evidence-based literature exists to address whether stent-
supported angioplasty can improve the long-term results of
PFA’s PTA. In our institutions, stent placement was
preferred selectively for cases with evidence of flow-
limiting dissection or elastic recoil of the treated segment
by balloon PTA. Furthermore, balloon angioplasty alone
does not eliminate the option of ‘open’ PFA repair in the
future and, therefore, primary PFA stent placement should
be avoided.
During the follow-up, the median ABI in our series was
significantly improved, but mirroring the data from open
PFA repair, the change in ABI in the immediate post-
operative period after PTA may not reflect the final
clinical outcome, especially for diabetic patients.15 The
clinical improvement in wound healing and the increase of
pain-free walking distance on a standardised treadmill
test are more objective parameters. An additional issue of
great importance, especially to the patients, was the
relief of their nocturnal pain symptoms. However, the
present study has some clear limitations. The small
number of patients treated with PTA of PFA does not allow
extensive statistical evaluation and analysis to identify
factors influencing the PTA results. During the mid-term
follow-up, we experienced three PTA pitfalls but we failed
to identify any particular reasons related to these
failures.
There is no doubt that the ‘open’ repair of PFAOD
remains the gold standard. However, if a more technically
demanding femorocrural bypass is not feasible, balloon
angioplasty of the PFA might play an important role in
preserving limb viability and function in selected cases with
sufficient runoff.
Conclusions
Revascularisation of PFA with endovascular means in
selected CLI patients with rest pain or minor tissue loss is
essential because of its important role as a collateral
circuit. The mid-term results of our series showed that the
PTA of PFA is safe, effective and minimises the perioper-
ative risks. In summary, if surgical repair of PFA is linked
to high risk of cardiovascular events or it is technically
demanding, the endovascular treatment of PFA seems to
be a useful tool and may be considered as bailout
treatment.
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